Ma, Y., Pannicke, U., Schwarz, K. and Lieber, M. R. (2002). Hairpin opening and overhang processing by an Artemis/DNA-<strong>de</strong>pen<strong>de</strong>nt protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108, 781-94. Ma, Y. Q. and Geng, J. G. (2000). Heparan sulfate-like proteoglycans mediate adhesion of human malignant me<strong>la</strong>noma A375 cells to P-selectin un<strong>de</strong>r flow. J Immunol 165, 558-65. MacLennan, I. C. (1994). Germinal centers. Annu Rev Immunol 12, 117-39. Macpherson, A. J., Lamarre, A., McCoy, K., Harriman, G. R., O<strong>de</strong>rmatt, B., Dougan, G., Hengartner, H. and Zinkernagel, R. M. (2001). IgA production without mu or <strong>de</strong>lta chain expression in <strong>de</strong>veloping B cells. Nat Immunol 2, 625-31. Madisen, L. and Groudine, M. (1994). I<strong>de</strong>ntification of a locus control region in the immunoglobulin heavy-chain locus that <strong>de</strong>regu<strong>la</strong>tes c-myc expression in p<strong>la</strong>smacytoma and Burkitt's lymphoma cells. Genes Dev 8, 2212-26. Makatsori, E., Karamanos, N. K., Papadogiannakis, N., Hjerpe, A., Anastassiou, E. D. and Tsegenidis, T. (2001). Synthesis and distribution of glycosaminoglycans in human leukemic B- and T-cells and monocytes studied using specific enzymic treatments and highperformance liquid chromatography. Biomed Chromatogr 15, 413-7. Maki, R., Roe<strong>de</strong>r, W., Traunecker, A., Sidman, C., Wabl, M., Raschke, W. and Tonegawa, S. (1981). The role of DNA rearrangement and alternative RNA processing in the expression of immunoglobulin <strong>de</strong>lta genes. Cell 24, 353-65. Manis, J. P., Dudley, D., Kaylor, L. and Alt, F. W. (2002a). IgH c<strong>la</strong>ss switch recombination to IgG1 in DNA-PKcs-<strong>de</strong>ficient B cells. Immunity 16, 607-17. Manis, J. P., Tian, M. and Alt, F. W. (2002b). Mechanism and control of c<strong>la</strong>ss-switch recombination. Trends Immunol 23, 31-9. Manis, J. P., van <strong>de</strong>r Stoep, N., Tian, M., Ferrini, R., Davidson, L., Bottaro, A. and Alt, F. W. (1998). C<strong>la</strong>ss switching in B cells <strong>la</strong>cking 3' immunoglobulin heavy chain enhancers. J Exp Med 188, 1421-31. Manser, T. (2002). Effector BCRs: insi<strong>de</strong> information on IgG. Nat Immunol 3, 114-6. Martensson, A., Argon, Y., Melchers, F., Dul, J. L. and Martensson, I. L. (1999). Partial block in B lymphocyte <strong>de</strong>velopment at the transition into the pre-B cell receptor stage in Vpre-B1-<strong>de</strong>ficient mice. Int Immunol 11, 453-60. Martensson, I. L., Keenan, R. A. and Licence, S. (2007). The pre-B-cell receptor. Curr Opin Immunol 19, 137-42. Martin, S. W. and Goodnow, C. C. (2002). Burst-enhancing role of the IgG membrane tail as a molecu<strong>la</strong>r <strong>de</strong>terminant of memory. Nat Immunol 3, 182-8. Mason, J. O., Williams, G. T. and Neuberger, M. S. (1988). The half-life of immunoglobulin mRNA increases during B-cell differentiation: a possible role for targeting to membrane-bound polysomes. Genes Dev 2, 1003-11. Mather, E. L. and Perry, R. P. (1983). Methy<strong>la</strong>tion status and DNase I sensitivity of immunoglobulin genes: changes associated with rearrangement. Proc Natl Acad Sci U S A 80, 4689-93. Matthias, P. and Baltimore, D. (1993). The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region. Mol Cell Biol 13, 1547-53. McBri<strong>de</strong>, K. M., Barreto, V., Ramiro, A. R., Stavropoulos, P. and Nussenzweig, M. C. (2004). Somatic hypermutation is limited by CRM1-<strong>de</strong>pen<strong>de</strong>nt nuclear export of activationinduced <strong>de</strong>aminase. J Exp Med 199, 1235-44. McEver, R. P., Moore, K. L. and Cummings, R. D. (1995). Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem 270, 11025-8. 166
Meek, K. D., Hasemann, C. A. and Capra, J. D. (1989). Novel rearrangements at the immunoglobulin D locus. Inversions and fusions add to IgH somatic diversity. J Exp Med 170, 39-57. Me<strong>la</strong>med, D. and Nemazee, D. (1997). Self-antigen does not accelerate immature B cell apoptosis, but stimu<strong>la</strong>tes receptor editing as a consequence of <strong>de</strong>velopmental arrest. Proc Natl Acad Sci U S A 94, 9267-72. Melchers, F., Karasuyama, H., Haasner, D., Bauer, S., Kudo, A., Sakaguchi, N., Jameson, B. and Rolink, A. (1993). The surrogate light chain in B-cell <strong>de</strong>velopment. Immunol Today 14, 60-8. Melchers, F., ten Boekel, E., Yamagami, T., An<strong>de</strong>rsson, J. and Rolink, A. (1999). The roles of preB and B cell receptors in the stepwise allelic exclusion of mouse IgH and L chain gene loci. Semin Immunol 11, 307-17. Merrell, K. T., Benschop, R. J., Gauld, S. B., Aviszus, K., Decote-Ricardo, D., Wysocki, L. J. and Cambier, J. C. (2006). I<strong>de</strong>ntification of anergic B cells within a wild-type repertoire. Immunity 25, 953-62. Michaelson, J. S., Giannini, S. L. and Birshtein, B. K. (1995). I<strong>de</strong>ntification of 3' alpha-hs4, a novel Ig heavy chain enhancer element regu<strong>la</strong>ted at multiple stages of B cell differentiation. Nucleic Acids Res 23, 975-81. Miller, J. R. (2002). The Wnts. Genome Biol 3, REVIEWS3001. Mimura, Y., Son<strong>de</strong>rmann, P., Ghir<strong>la</strong>ndo, R., Lund, J., Young, S. P., Goodall, M. and Jefferis, R. (2001). Role of oligosacchari<strong>de</strong> residues of IgG1-Fc in Fc gamma RIIb binding. J Biol Chem 276, 45539-47. Mizuguchi, S., Uyama, T., Kitagawa, H., Nomura, K. H., Dejima, K., Gengyo-Ando, K., Mitani, S., Sugahara, K. and Nomura, K. (2003). Chondroitin proteoglycans are involved in cell division of Caenorhabditis elegans. Nature 423, 443-8. Moiseeva, E. P., Williams, B., Goodall, A. H. and Samani, N. J. (2003). Galectin-1 interacts with beta-1 subunit of integrin. Biochem Biophys Res Commun 310, 1010-6. Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S. and Papaioannou, V. E. (1992). RAG-1-<strong>de</strong>ficient mice have no mature B and T lymphocytes. Cell 68, 869-77. Mostos<strong>la</strong>vsky, R., Singh, N., Kirillov, A., Pe<strong>la</strong>nda, R., Cedar, H., Chess, A. and Bergman, Y. (1998). Kappa chain monoallelic <strong>de</strong>methy<strong>la</strong>tion and the establishment of allelic exclusion. Genes Dev 12, 1801-11. Mostos<strong>la</strong>vsky, R., Singh, N., Tenzen, T., Goldmit, M., Gabay, C., Elizur, S., Qi, P., Reubinoff, B. E., Chess, A., Cedar, H. et al. (2001). Asynchronous replication and allelic exclusion in the immune system. Nature 414, 221-5. Moyron-Quiroz, J. E., Partida-Sanchez, S., Donis-Hernan<strong>de</strong>z, R., Sandoval-Montes, C. and Santos-Argumedo, L. (2002). Expression and function of CD22, a B-cell restricted molecule. Scand J Immunol 55, 343-51. Mumm, J. S. and Kopan, R. (2000). Notch signaling: from the outsi<strong>de</strong> in. Dev Biol 228, 151-65. Mundt, C., Licence, S., Shimizu, T., Melchers, F. and Martensson, I. L. (2001). Loss of precursor B cell expansion but not allelic exclusion in VpreB1/VpreB2 double-<strong>de</strong>ficient mice. J Exp Med 193, 435-45. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. and Honjo, T. (2000). C<strong>la</strong>ss switch recombination and hypermutation require activation-induced cytidine <strong>de</strong>aminase (AID), a potential RNA editing enzyme. Cell 102, 553-63. Muramatsu, M., Sankaranand, V. S., Anant, S., Sugai, M., Kinoshita, K., Davidson, N. O. and Honjo, T. (1999). Specific expression of activation-induced cytidine <strong>de</strong>aminase 167
- Page 1:
UNIVERSITE DE LIMOGES Ecole doctora
- Page 4 and 5:
de m’avoir donnée le goût pour
- Page 6 and 7:
KO : « knock-out » : délétion d
- Page 8 and 9:
Figure 27 : Les trois types de N-gl
- Page 10 and 11:
5.2.2. Les galectines, les voies No
- Page 13 and 14:
Afin d’assurer la défense de l
- Page 15:
conduire les cellules B au long de
- Page 19 and 20:
Les immunoglobulines sont des hét
- Page 21 and 22:
antigènes et dans la transduction
- Page 23 and 24:
1.2.2 Le Locus Igλ Les gènes de c
- Page 25 and 26:
empêcher des recombinaisons illég
- Page 27 and 28:
de l’ADN est réalisée par les p
- Page 29 and 30:
Figure 8 : Les nucléotides N et P.
- Page 31 and 32:
séquences Ig (Goodhardt et al., 19
- Page 33 and 34:
B, le nombre de cellules exprimant
- Page 35 and 36:
Des promoteurs ont également été
- Page 37 and 38:
maturation : aux stades précoces,
- Page 39 and 40:
jusqu’à Cδ, ne supprime pas pou
- Page 41 and 42:
3.1 La phase indépendante des anti
- Page 43 and 44:
Novobrantseva et al., 1999) et que
- Page 45 and 46:
Figure 14 : Bilan des blocages part
- Page 47 and 48:
Dendritic Cells »). Elles devienne
- Page 49 and 50:
sécrétrices est controversée. De
- Page 51 and 52:
et al., 2000; Chumley et al., 2000;
- Page 53 and 54:
La commutation isotypique, permetta
- Page 55 and 56:
L’action des cytokines semble s
- Page 57 and 58:
l’hypermutation (Muramatsu et al.
- Page 59 and 60:
IV. L’activation des lymphocytes
- Page 61 and 62:
La translocation du BCR après pont
- Page 63 and 64:
protéines. La protéine ZAP-70 ét
- Page 65 and 66:
comme NF-κB (Krappmann et al., 200
- Page 67 and 68:
démontré que CD22 était continue
- Page 69 and 70:
Figure 24 : Comparaison des région
- Page 71 and 72:
Au cours du développement B, le pr
- Page 73 and 74:
membranaire s’avère possible exp
- Page 75 and 76:
IgM/IgD (Brink et al., 1992; Spanop
- Page 77 and 78:
V. « Glycannes et glycoconjugués
- Page 79 and 80:
Groupe d'enzymes Sialyltransférase
- Page 81 and 82:
L’édification d’une structure
- Page 83 and 84:
5.1.2. La O-glycosylation des prot
- Page 85 and 86:
• la O-glucosylation qui a lieu s
- Page 87 and 88:
Les protéoglycannes peuvent varier
- Page 89 and 90:
o L’Héparane Sulfate (HS) et l
- Page 91 and 92:
C’est le premier hexosamine greff
- Page 93 and 94:
égion constante. L’analyse des d
- Page 95 and 96:
pathologies pour lesquelles l’ars
- Page 97 and 98:
intégrines VLA-4, VLA-5 et α4β7,
- Page 99 and 100:
thymocytes double négatifs CD4- CD
- Page 101 and 102:
délétion conditionnelle des gène
- Page 103 and 104:
Dans la MEC, les protéoglycannes f
- Page 105 and 106:
endothéliale, de façon à permett
- Page 107 and 108:
Résultats - Discussion 107
- Page 109 and 110:
Première partie : les BCR modifié
- Page 111 and 112:
Article 1 “Premature expression o
- Page 113 and 114:
Article 2 “B cells carying an IgE
- Page 115 and 116: Demande de dépôt de brevet Etabli
- Page 117 and 118: mécanismes relèvent les différen
- Page 119 and 120: Etablissement et caractérisation d
- Page 121 and 122: AUSUBEL, 2000, Wiley and son Inc, L
- Page 123 and 124: 4) Dosage du taux des IgG1 sérique
- Page 125 and 126: - distribution d’un antisérum an
- Page 127 and 128: périphériques expriment pour envi
- Page 129 and 130: C. CONCLUSION Ce travail a reposé
- Page 131 and 132: Deuxième partie : les glycosaminog
- Page 133 and 134: Article 3 “Modulation of glycotra
- Page 135 and 136: Perspectives 135
- Page 137 and 138: L’état des réflexions sur les i
- Page 139 and 140: équipes de Tsubata et Goodnow avai
- Page 141 and 142: L’ouverture d’un nouveau champ
- Page 143 and 144: « Lymphomagenèse » dirigé par l
- Page 145 and 146: Annexes 145
- Page 147 and 148: Article 4 “RNA surveillance down-
- Page 149 and 150: Article 5 “Light chain inclusion
- Page 151 and 152: Références Bibliographiques 151
- Page 153 and 154: Abney, E. R., Cooper, M. D., Kearne
- Page 155 and 156: Brink, R., Goodnow, C. C., Crosbie,
- Page 157 and 158: Cogne, M., Lansford, R., Bottaro, A
- Page 159 and 160: Franke, T. F., Kaplan, D. R., Cantl
- Page 161 and 162: Hauke, G., Epplen, J. T., Chluba, J
- Page 163 and 164: Kao, Y. H., Lee, G. F., Wang, Y., S
- Page 165: Lieberson, R., Giannini, S. L., Bir
- Page 169 and 170: Oberdoerffer, P., Novobrantseva, T.
- Page 171 and 172: Poellinger, L., Yoza, B. K. and Roe
- Page 173 and 174: Sato, M., Adachi, T. and Tsubata, T
- Page 175 and 176: Functional immunoglobulin transgene
- Page 177 and 178: Vilen, B. J., Famiglietti, S. J., C
- Page 179 and 180: Zarrin, A. A., Tian, M., Wang, J.,